Maxcyte (MXCT) EBT Margin Growth (1y) (2021 - 2026)
Maxcyte (MXCT) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 165.00 |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn | 2,321.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,321.00 |
| Mar 31, 2026 | -677.00 |
| Dec 31, 2025 | 37,623.00 |
| Sep 30, 2025 | -4,025.00 |
| Jun 30, 2025 | 4,360.00 |
| Mar 31, 2025 | 7,184.00 |
| Dec 31, 2024 | -15,513.00 |
| Sep 30, 2024 | 12,916.00 |
| Jun 30, 2024 | -7,262.00 |
| Mar 31, 2024 | 4,862.00 |
| Dec 31, 2023 | 34,916.00 |
| Sep 30, 2023 | 1,880.00 |
| Jun 30, 2023 | -1,177.00 |
| Mar 31, 2023 | 3,558.00 |
| Dec 31, 2022 | -30,410.00 |
| Sep 30, 2022 | -26,500.00 |
| Jun 30, 2022 | -3,960.00 |
| Mar 31, 2022 | -10,456.00 |
| Dec 31, 2021 | -1,097.00 |
| Sep 30, 2021 | 3,206.00 |